Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study. Sun H, Ren P, Chen Y, Lan L, et al. BMC Cancer 2023;23:198.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun H, Ren P, Chen Y, Lan L, et al. Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study. BMC Cancer 2023;23:198.
PMID: 36864384